LaserOptek Co

LaserOptek Co EBITDA per Share

The EBITDA per Share of LaserOptek Co (199550.KQ) as of Oct 15, 2026 is 76.44 KRW. In the previous year, EBITDA per Share was 535.74 KRW — a change of -85.73% (lower).

EBITDA per Share

76.44KRW

YoY

-85.73%

Last updated:

EBITDA per Share of LaserOptek Co is 2024 76.44 KRW. EBITDA per Share of LaserOptek Co was 2023 535.74 KRW. It decreases by -85.73% lower compared to the previous year.

The LaserOptek Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
79.69 KRW
Jan 1, 2020
-15.01 KRW
Jan 1, 2021
119.30 KRW
Jan 1, 2022
299.39 KRW
Jan 1, 2023
535.74 KRW
Jan 1, 2024
76.44 KRW
The LaserOptek Co EBITDA per Share history
YEAREBITDA per ShareYoY
76.44KRW-85.73%
535.74KRW+78.94%
299.39KRW+150.96%
119.30KRW-894.70%
-15.01KRW-118.84%
79.69KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LaserOptek Co Stock analysis

What does LaserOptek Co do? LaserOptek Co Ltd is a South Korean company headquartered in Seongnam, Gyeonggi-Do, operating within the Health Care sector, specifically in the Health Care Equipment & Supplies industry. The company went public on February 1, 2024, with the ticker symbol 199550.KQ and ISIN KR7199550005. LaserOptek focuses on the development, manufacturing, and sale of cosmetic and medical laser devices. Its products are designed for skin care and disease treatment applications, utilizing laser source technology. The company distributes its products across multiple regions, including Korea, Asia, the Middle East, Europe, and the United States. LaserOptek's operations are centered around the production of medical devices that leverage laser technology for therapeutic and aesthetic purposes. The company's website is https://www.laseroptek.com/. LaserOptek Co Ltd is a Korea-based firm engaged in the manufacture and sale of laser-based medical equipment. It serves both domestic and international markets, with a presence in key global regions. The company's business model emphasizes the development and commercialization of innovative laser solutions for healthcare applications. Its product portfolio targets the cosmetic and medical device markets, offering devices that address skin care needs and medical treatments through laser technology. LaserOptek Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LaserOptek Co stock

EBITDA per Share of LaserOptek Co is 76.44 KRW in 2024.

EBITDA per Share of LaserOptek Co changed from 535.74 KRW to 76.44 KRW, representing a -85.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share LaserOptek Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — LaserOptek Co

All Key Metrics — LaserOptek Co